Updates on Advanced Breast Cancer: Local Management and Other New Perspectives

This multidisciplinary conference covers emerging local and systemic treatments for advanced breast cancer, including precision medicine, immunotherapy, cellular therapies and liquid biopsies. Pre-conference workshops and case-based discussions focus on applying new evidence to coordinated, patient-centered care.

Audience: Medical oncologists, surgical oncologists, physicians, advanced practice clinicians, nurses, pharmacists, physician associates, social workers, counselors and trainees.

February 25–26, 2027, in person. The dated narrative schedule lists February 25 workshops 1:00–5:00 PM CST and February 26 conference 8:00 AM–5:00 PM, followed by reception/networking 5:00–6:00 PM. The displayed overall window follows that narrative, including the reception, and does not mean continuous programming. Schedule conflict: the same page’s calendar metadata instead span February 25 at 12:30 PM through February 26 at 5:30 PM. Confirm the final attendance window with MD Anderson before travel. Advance registration deadline: January 25, 2027; later attendance availability is not established. A PEP profile is required. Fees, checkout capacity and workshop availability are not independently verified. The organizer advertises up to 11 AMA PRA Category 1 Credits; eligibility conditions and other credit categories differ.

Official event information